作者
Zeenat Mirza, Ashraf Ali, Ghulam Md Ashraf, Mohammad A Kamal, Adel M Abuzenadah, Adeel G Choudhary, Ghazi A Damanhouri, Ishfaq A Sheikh
发表日期
2014/3/1
来源
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)
卷号
13
期号
2
页码范围
213-225
出版商
Bentham Science Publishers
简介
Alzheimer’s disease (AD) is a progressive neurological disease of the brain leading to the irreversible loss of neurons and intellectual abilities. Diabetes mellitus type 2 (T2DM) is a metabolic disorder that is characterized by high blood glucose in the context of insulin resistance and relative insulin deficiency. The prevalence of AD and T2DM is increasing at an alarming rate and has become a major public health concern worldwide. The clinico-pathological relationship between AD and T2DM has been debated for more than a decade. Recent epidemiological studies have provided direct evidence that T2DM is a strong risk factor for AD and numerous studies have demonstrated that patients with diabetes have an increased risk of developing AD as compared with healthy individuals. The underlying biological mechanisms that link the development of diabetes with AD are not fully understood and therefore are worth …
学术搜索中的文章
Proteomics approaches to understand linkage between Alzheimer’s disease and type 2 diabetes mellitus
Z Mirza, A Ali, G Md Ashraf, MA Kamal… - CNS & Neurological Disorders-Drug Targets (Formerly …, 2014